Patent details

EP1706095 Title: COMPOSITIONS FOR LOCALIZED THERAPY OF THE EYE, COMPRISING PREFERABLY TRIAMCINOLONE ACETONIDE AND HYALURONIC ACID

Basic Information

Publication number:
EP1706095
PCT Application Number:
PCT/US/2005/001371
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP057057846
PCT Publication Number:
WO/2005/072701
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
COMPOSITIONS FOR LOCALIZED THERAPY OF THE EYE, COMPRISING PREFERABLY TRIAMCINOLONE ACETONIDE AND HYALURONIC ACID
French Title of Invention:
COMPOSITIONS POUR THERAPIE LOCALISEE DE L'OEIL, DE PREFERENCE A BASE DE TRIAMCINOLONE ACETONIDE ET D'ACIDE HYALURONIQUE
German Title of Invention:
ZUSAMMENSETZUNGEN FÜR DIE LOKALISIERTE THERAPIE DES AUGES, VORZUGSWEISE ENTHALTEND TRIAMCINOLON-ACETONID UND HYALURONSÄURE
SPC Number:

Dates

Filing date:
14/01/2005
Grant date:
24/12/2008
EP Publication Date:
24/12/2008
PCT Publication Date:
11/08/2005
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
04/10/2006
EP B1 Publication Date:
24/12/2008
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
14/01/2009
Expiration date:
14/01/2025
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
14/01/2005
 
 

Name:
ALLERGAN INC.
Address:
2525 Dupont Drive, Irvine CA 92612, United States (US)

Inventor

1

Name:
BURKE James, A.
Address:
United States (US)

2

Name:
WHITCUP Scott, M.
Address:
United States (US)

3

Name:
OLEJNIK Orest
Address:
United States (US)

4

Name:
HUGHES Patrick, M.
Address:
United States (US)

Priority

Priority Number:
537620 P
Priority Date:
20/01/2004
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 9/10;
Filing date Document type Number of pages